首页> 外文期刊>癌症生物学与医学(英文版 ) >Targeting fatty acid synthase sensitizes human nasopharyngeal carcinoma cells to radiationvia downregulating frizzled class receptor 10
【24h】

Targeting fatty acid synthase sensitizes human nasopharyngeal carcinoma cells to radiationvia downregulating frizzled class receptor 10

机译:靶向脂肪酸合酶通过下调卷曲的类受体10使人鼻咽癌细胞对放射敏感

获取原文
获取原文并翻译 | 示例
       

摘要

Objective:Our aim was to test the hypothesis that fatty acid synthase(FASN)expression contributes to radioresistance of nasopharyngeal carcinoma(NPC)cells and that inhibiting FASN enhances radiosensitivity.Methods:Targeting FASN using epigallocatechin gallate(EGCG)or RNA interference in NPC cell lines that overexpress endogenous FASN was performed to determine their effects on cellular response to radiationin vitro using MTT and colony formation assays,andin vivo using xenograft animal models.Western blot,immunohistochemistry,real-time PCR arrays,and real-time RT-PCR were used to determine the relationship between FASN and frizzled class receptor 10(FZD10)expression.FZD10 knockdown and overexpression were used to determine its role in mediating FASN function in cellular response to radiation.Immunohistochemical staining was used to determine FASN and FZD10 expressions in human NPC tissues,followed by analysis of their association with the overall survival of patients.Results:FASN knockdown or inhibition significantly enhanced radiosensitivity of NPC cells,bothin vitro andin vivo.There was a positive association between FASN and FZD10 expression in NPC cell lines grown as monolayers or xenografts,as well as human tissues.FASN knockdown reduced FZD10 expression,and rescue of FZD10 expression abolished FASN knockdown-induced enhancement of radiosensitivity.FASN and FZD10 were both negatively associated with overall survival of NPC patients.Conclusions:FASN contributes to radioresistance,possiblyvia FZD10 in NPC cells.Both FZD10 and FASN expressions were associated with poor outcomes of NPC patients.EGCG may sensitize radioresistance by inhibiting FASN and may possibly be developed as a radiosensitizer for better treatment of NPCs.

著录项

  • 来源
    《癌症生物学与医学(英文版 )》 |2020年第3期|740-752|共13页
  • 作者单位

    Guangdong Provincial Key Laboratory for Breast Cancer Diagnosis and Treatment Cancer Hospital of Shantou University Medical College Shantou 515041 China;

    Guangdong Provincial Key Laboratory for Breast Cancer Diagnosis and Treatment Cancer Hospital of Shantou University Medical College Shantou 515041 China;

    Guangdong Provincial Key Laboratory for Breast Cancer Diagnosis and Treatment Cancer Hospital of Shantou University Medical College Shantou 515041 China;

    Guangdong Provincial Key Laboratory for Breast Cancer Diagnosis and Treatment Cancer Hospital of Shantou University Medical College Shantou 515041 China;

    Guangdong Provincial Key Laboratory for Breast Cancer Diagnosis and Treatment Cancer Hospital of Shantou University Medical College Shantou 515041 China;

    Department of Cancer Biology University of Toledo College of Medicine and Life Sciences Toledo OH 43614 USA;

    Guangdong Provincial Key Laboratory for Breast Cancer Diagnosis and Treatment Cancer Hospital of Shantou University Medical College Shantou 515041 China;

  • 收录信息 中国科学引文数据库(CSCD);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号